Keywords: Δ9-تتراهیدروکانیابینول; 5-HT1A; serotonin 1A receptor; AE; adverse events; AIDS; acquired immunodeficiency syndrome; CB1; cannabinoid-one receptor; CB2; cannabinoid-two receptor; CBD; cannabidiol; CBDA; cannabidiolic acid; CRISP-R; Clustered Regularly Interspaced Short Palindrom
مقالات ISI Δ9-تتراهیدروکانیابینول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Δ9-تتراهیدروکانیابینول; Î9-tetrahydrocannabinol; Cannabidiol; Cannabinol; Hard-cap espresso extraction; Gas chromatography-mass spectrometry; Ion mobility spectrometry;
Keywords: Δ9-تتراهیدروکانیابینول; AcOH; acetic acid; ACN; acetonitrile; APCI; atmospheric pressure chemical ionization; BSTFA; N,O-bis(trimethylsilyl)trifluoroacetamide; CBCA; cannabichromenic acid; CBC; cannabichromene; CBDA; cannabidiolic acid; CBD; cannabidiol; CBDVA; cannabidivarinic
Keywords: Δ9-تتراهیدروکانیابینول; 1-AA; 1-aminoanthracene; 2-EP; 2-ethylpyridine; 2-PIC; 2-picolylamine; AMP; amphetamine; AMY1; amylose tris-(3,5-dimethyl-phenylcarbamate); BEH; bridged ethylene hybrid silica; CCH; cannabicyclohexanol; CEL1; cellulose tris-(3,5-dimethyl-phenylcarbamate);
Keywords: Δ9-تتراهیدروکانیابینول; 2-AG; 2-arachidonoyl glycerol; 11-nor-THC-COOH; 11-nor-tetrahydrocannabinol-9-caboxylic acid; 11-OH-THC; 11-hydroxy-tetrahydrocannabinol; 8-OH-THC; 8-hydroxy-tetrahydrocannabinol; CB; cannabinoid; CB1R; Type I cannabinoid receptor; CB2R; Type II cannabino
Keywords: Δ9-تتراهیدروکانیابینول; Cannabis; Crack cocaine; People who use drugs; Î9-tetrahydrocannabinol; Cannabidiol; Cannabinoids;
Keywords: Δ9-تتراهیدروکانیابینول; CBD; cannabidiol; Î9-THC; Î9-tetrahydrocannabinol; EOS; equation of state; PLOT-cryo; porous layered open tubular cryoadsorption; GC-MS; gas chromatography-mass spectrometry; NBT; normal boiling temperature; FID; flame ionization detection; INChI; I
Keywords: Δ9-تتراهیدروکانیابینول; cannabis; marijuana; edible; cannabinoid; children; toxicology; ingestion; PICU; Pediatric intensive care unit; THC; Î9-tetrahydrocannabinol; TW; Text words;
Keywords: Δ9-تتراهیدروکانیابینول; ABHD; α/β hydrolase domain containing protein; Î9-THC; Î9-tetrahydrocannabinol; 2-AG; 2-arachidonoyl glycerol; 2-OG; 2-oleoyl glycerol; DGAT; acyl-CoA:diacylglycerol acyltransferase; MGAT; acyl-CoA:monoacylglycerol acyltransferase; ATGL; adipose trigl
Keywords: Δ9-تتراهیدروکانیابینول; BMP15; bone morphogenetic protein 15; BPA; bisphenol-A; COC; cumulus cell-oocyte complex; GDF9; growth differentiation factor 9; MDMA; 3,4-methylenedioxymethamphetamine; THC; Î9-tetrahydrocannabinol; Oocyte; Cumulus cells; Gap junctions; Oocyte growth fa
Keywords: Δ9-تتراهیدروکانیابینول; AC; adenyl cyclase; AD; Alzheimer's disease; 2-AG; 2-arachidonoylglycerol; ABHD6; α,β hydrolase 6; AEA; arachidonylethanolamide/anandamide; ALS; amyotrophic lateral sclerosis; BBB; blood brain barrier; cAMP; cyclic adenosine monophosphate; CBD; cannabid
Keywords: Δ9-تتراهیدروکانیابینول; Psychotropic substances; Indoor pollution; Airborne particulates; Cocaine; Î9-Tetrahydrocannabinol; Amphetamines;
Keywords: Δ9-تتراهیدروکانیابینول; % OAE; percentage of open arm entries; % OAT; percentage of time spent on the open arms; 5-HT1A; 5-hydroxytryptamine 1A; BrdU; bromodeoxyuridine; CBD; cannabidiol; CNS; central nervous system; CUS; chronic unpredictable stress; DAB; 3-3'-diamino-benzidi
Keywords: Δ9-تتراهیدروکانیابینول; Cer; ceramide(s); 4-HPR; N-(4-hydroxyphenyl)retinamide or fenretinide; Aβ; amyloid β peptides; DEGS1; drosophila degenerative spermatocyte 1; DEGS2; drosophila degenerative spermatocyte 2; Des1; dihydroceramide desaturase 1; Des2; dihydroceramide desatu
Keywords: Δ9-تتراهیدروکانیابینول; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; ALP; alprazolam; AM; amphetamine; ATC; Anatomical Therapeutic Classification; ATS; amphetamine-type stimulant; BE; benzoylecgonine; BQ; benchmark quotient; BW; body weight; CAF; caffeine; CBD; cannabid
Keywords: Δ9-تتراهیدروکانیابینول; Î9-tetrahydrocannabinol; 2-arachinodoylglycerol; Anandamide; Cannabis; Cytotrophoblast; Endocannabinoid system; Human placenta; Syncytiotrophoblast;
Keywords: Δ9-تتراهیدروکانیابینول; 2AG; 2-Arachidonoylglycerol; AEA; Anandamide; CBD; Cannabidiol; FAAH; Fatty acid amide hydrolase; FAAH-2; Fatty acid amide hydrolase-2; MGL; Monoacylglycerol lipase; NAAA; N-Acylethanolamine acid amidase; NAPE-PLD; N-Acylphosphatidylethanolamine phospholi
Keywords: Δ9-تتراهیدروکانیابینول; 2-AG; 2-arachidonyl glycerol; AEA; anandamide; CB; cannabinoid receptor; CBD; cannabidiol; COX-2; cyclooxygenase 2; ERK1/2; extracellular signal-regulated kinase ½; FAAH; fatty acid amide hydrolase; IFN; interferon; IL; interleukin; iNOS; inducible nitri
Keywords: Δ9-تتراهیدروکانیابینول; OCEs; Oral cannabis extracts; LGS; Lennox-Gastaut syndrome; AEs; Adverse Events; CO; Colorado; Î9-THC; Î9-Tetrahydrocannabinol; Epilepsy; Antiepileptic drugs; Pediatric; Cohort studies; Cannabidiol; Medical marijuana;
Keywords: Δ9-تتراهیدروکانیابینول; Akt; protein kinase B; CB1; cannabinoid type-1 receptor; CB2; cannabinoid type-2 receptor; D2; dopamine type-2 receptor; Î9-THC; Î9-tetrahydrocannabinol; EEG; electroencephalography; ERK; extracellular signal-regulated kinase; FAAH; fatty acid amide hyd
Keywords: Δ9-تتراهیدروکانیابینول; Touchscreen; Rhesus monkey; Working memory; Delayed nonmatching to sample; Î9-Tetrahydrocannabinol; Methylphenidate;
Keywords: Δ9-تتراهیدروکانیابینول; nouvelles drogues; phénéthylamines substituées; cathinones substituées; méthoxétamine; cannabinoïdes de synthèse; 4-FA; 4-fluoroamphétamine; 4-MA; 4-méthylamphétamine; CB1; récepteurs cannabinoïdes de type 1; CS; cannabinoïdes de synthèse;
Keywords: Δ9-تتراهیدروکانیابینول; 5-HT; serotonin; Î9-THC; Î9-tetrahydrocannabinol; ACh; acetylcholine; AChEI; cholinesterase inhibitors; AD; Alzheimer's disease; CB; cannabinoid; CBC; cannabichromene; CBG; cannabigeroland; CBN; cannabinol; CNS; central nervous system; CMS; chronic unpr
Keywords: Δ9-تتراهیدروکانیابینول; DAGLα; diacylglycerol lipase alpha; F344; Fischer 344; FAAH; fatty acid amino hydrolase; LEW; Lewis; LGP; lateral globus pallidus; MAGL; monoacylglycerol lipase; NAcc; nucleus accumbens; NAPE-PLD; N-acyl phosphatidylethanolamine phospholipase D; PFc; pre
Keywords: Δ9-تتراهیدروکانیابینول; 6ACM; 6-acetylmorphine; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulants; BE; benzoylecgonine; CE; cocaethylene; CO; cocaine; DAs; drugs of abuse; DIA; diazepam; EDDP; 2-ethylene-1,5-dimethyl-3,3-diphenylpyrrolidine; EPs; emerging pollut
Keywords: Δ9-تتراهیدروکانیابینول; a; aerobic stabilization; 6ACM; 6-acetylmorphine; ADI; acceptable daily intake; AF; assessment factor; ALP; alprazolam; AM; amphetamine; ATS; amphetamine-type stimulant; BAS; biologic-activated sludge; BB; bacterial bed; BE; benzoylecgonine; bf; belt-filt
Keywords: Δ9-تتراهیدروکانیابینول; LOQ; Limits of quantification; OHCOT; Trans-3â²-hydroxycotinine; SES; Socioeconomic status; THC; Î9-tetrahydrocannabinol; THCCOOH; 11-nor-9-carboxy-THC;
Optimization of Î9-tetrahydrocannabinolic acid synthase production in Komagataella phaffii via post-translational bottleneck identification
Keywords: Δ9-تتراهیدروکانیابینول; CBGA; cannabigerolic acid; THC; Î9-tetrahydrocannabinol; THCA; Î9-tetrahydrocannabinolic acid; THCAS; Î9-tetrahydrocannabinolic acid synthase; CNE1p; calnexin-like protein; PDI1p; protein disulfide isomerase; Ero1p; endoplasmic reticulum oxidoreductin
Commercial cannabis consumer products part 2: HPLC-DAD quantitative analysis of cannabis cannabinoids
Keywords: Δ9-تتراهیدروکانیابینول; Cannabis cannabinoids; Commercial cannabis products; High performance liquid chromatography-diode array detection (HPLC-DAD); Î9-tetrahydrocannabinol; Cannabidiol;
Sex-specific effects of CB1 receptor antagonism and stress in adolescence on anxiety, corticosterone concentrations, and contextual fear in adulthood in rats
Keywords: Δ9-تتراهیدروکانیابینول; CB1; cannabinoid receptor type-1; PFC; prefrontal cortex; DH; dorsal hippocampus; PND; postnatal day; AM251; 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide; CORT; corticosterone; GAD67; glutamic acid decarboxyla
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Î9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis
Keywords: Δ9-تتراهیدروکانیابینول; cannabinoid; multiple sclerosis; pain; spasticity; Î9-tetrahydrocannabinol;
Î9-tetrahydrocannabivarin impairs epithelial calcium transport through inhibition of TRPV5 and TRPV6
Keywords: Δ9-تتراهیدروکانیابینول; TRPV; transient receptor potential vanilloid; THC; Î9-tetrahydrocannabinol; THCV; Î9-tetrahydrocannabivarin; CBDV; cannabidivarin; CBC; cannabichromene; CBD; cannabidiol; CBG; cannabigerol; CBGV; cannabigerovarin; THCVâOH; 11-hydroxy- Î9-tetrahydroca
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) method for the determination of cannabidiol (CBD), Î9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration o
Keywords: Δ9-تتراهیدروکانیابینول; Cannabidiol; Î9-Tetrahydrocannabinol; Liquid chromatography; Mass spectrometry; Cannabinoids extraction;
Commercial cannabis consumer products part 1: GC-MS qualitative analysis of cannabis cannabinoids
Keywords: Δ9-تتراهیدروکانیابینول; Cannabis cannabinoids; Commercial cannabis products; Gas chromatography-mass spectrometry (GC-MS); Î9-Tetrahydrocannabinol; Cannabidiol;
The potential of near infrared spectroscopy to estimate the content of cannabinoids in Cannabis sativa L.: A comparative study
Keywords: Δ9-تتراهیدروکانیابینول; Î8-THC; Î8- tetrahydrocannabinol; Î9-THC; Î9-tetrahydrocannabinol;; Î9-THCV; Î9-tetrahydrocannabivarin; CBD; cannabidiol;; CBC; cannabichromene; CBDV; cannabidivarin; CBG; cannabigerol; CBN; cannabinol; DT; detrending; MPLS; modified partial least s
Melatonin attenuates Î9-tetrahydrocannabinol-induced reduction in rat sperm motility and kinematics in-vitro
Keywords: Δ9-تتراهیدروکانیابینول; HAM; hyper-activated motility; SR141716; rimonabant; AM-630; iodopravadoline; THC; Î9-tetrahydrocannabinol; CB; cannabinoid receptor; CASA; computer-assisted sperm analyser; CSC; annabis sativa; ZP; zona pellucida; BWW; Biggers-Whitten-Whittingham; B
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation
Keywords: Δ9-تتراهیدروکانیابینول; JZL184; Rat; Monoacylglycerol lipase (MAGL); Inhibitory avoidance; Fear memory; Behavior; JZL184 [4-[Bis(1,3-benzodioxol-5-yl)hydroxymethyl]-1-piperidinecarboxylic acid 4-nitrophenyl ester]; MAGL inhibitor; SR141716 [5-(4-chlorophenyl)-1-(2,4-dichlorophen
Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production
Keywords: Δ9-تتراهیدروکانیابینول; AKT; Protein kinase B; Bcl-2; B-cell lymphoma 2; calcein-AM; calcein-acetoxymethylester; CBD; cannabidiol; CM-H2DCF-DA; 5,6-chloromethyl-2,7-dichlorodihydrofluorescin diacetate; COX IV; cytochrome c oxidase subunit IV; CsA; cyclosporin A; Cyt c; cytochrom
Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice
Keywords: Δ9-تتراهیدروکانیابینول; 2-AG; 2-arachidonoylglycerol; CB1; Cannabinoid receptor subtype 1; CB2; Cannabinoid receptor subtype 2; FAAH; Fatty acid amide hydrolase; JZL184; 4-nitrophenyl-4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate; JWH-018; Naphthalen-1-yl-
A Model of Î9-Tetrahydrocannabinol Self-administration and Reinstatement That Alters Synaptic Plasticity in Nucleus Accumbens
Keywords: Δ9-تتراهیدروکانیابینول; Cannabidiol; Î9-tetrahydrocannabinol; Drug abuse; Nucleus accumbens; Reinstatement; Synaptic plasticity;
Effects of chronic Î9-tetrahydrocannabinol treatment on Rho/Rho-kinase signalization pathway in mouse brain
Keywords: Δ9-تتراهیدروکانیابینول; Brain; Mice; RhoA; Rho-kinase; Î9-Tetrahydrocannabinol;
Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice
Keywords: Δ9-تتراهیدروکانیابینول; ANOVA; analysis of variance; AUC; area under the curve; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CP55,940; (2)-cis-3-[2-hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol; dNPA; D.NP(N-Me)AFLFQPQRFamide;
Development of a new extraction technique and HPLC method for the analysis of non-psychoactive cannabinoids in fibre-type Cannabis sativa L. (hemp)
Keywords: Δ9-تتراهیدروکانیابینول; CBD; cannabidiol; CBDA; cannabidiolic acid; CBG; cannabigerol; CBGA; cannabigerolic acid; CBC; cannabichromene; CBCA; cannabichromenic acid; CBN; cannabinol; CBNA; cannabinolic acid; Î9-THC; Î9-tetrahydrocannabinol; THCA; Î9-tetrahydrocannabinolic acid
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets
Keywords: Δ9-تتراهیدروکانیابینول; THC; Î9-tetrahydrocannabinol; 5-HT2B; serotonin 2B receptor; AC; adenylyl cyclase; AEA; anandamide; Akt; protein kinase B; cAMP; cyclic adenosine monophosphate; CBR; cannabinoid receptor; CB1R; cannabinoid receptor 1; CB2R; cannabinoid receptor 2; CNS; c
Research reportCannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice
Keywords: Δ9-تتراهیدروکانیابینول; CBD; cannabidiol; THC; Î9-tetrahydrocannabinol; Cannabinoids; Catalepsy; Typical antipsychotics; Fos expression; 5HT1A receptors;
Development of a novel immunoassay for herbal cannabis using a new fluorescent antibody probe, “Ultra Quenchbody”
Keywords: Δ9-تتراهیدروکانیابینول; Immunoassay; Fluorescence; Cannabis; Î9-Tetrahydrocannabinol; Drug screening;
Î9-Tetrahydrocannabinol reverses TNFα-induced increase in airway epithelial cell permeability through CB2 receptors
Keywords: Δ9-تتراهیدروکانیابینول; Î9-tetrahydrocannabinol (PubChem CID: 16078); AM251 (PubChem CID: 2125); SR144528 (PubChem CID: 3081355); HU-210 (PubChem CID: 9821569); ACEA (PubChem CID: 5311006); JWH133 (PubChem CID: 6918505); THC; Î9-tetrahydrocannabinol; ALI; air-liquid interface;
Pure Î9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Î9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages
Keywords: Δ9-تتراهیدروکانیابینول; BSA; albumin bovine serum; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CBC; cannabichromene; CBD; cannabidiol; CBG; cannabigerol; COX-2; cyclooxygenase-2; DAN; 2,3-diaminonaphthalene; DMSO; dimethyl sulfoxide (DMSO); DTT; 1,4-dithi
Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties
Keywords: Δ9-تتراهیدروکانیابینول; Tricyclic pyrazoles; Synthesis; Cannabinoid receptors; CB2 antagonism; Molecular modelling; Î9-THC; Î9-Tetrahydrocannabinol; 2-AG; 2-Arachidonoylglycerol; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; Central nervous system; T
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice
Keywords: Δ9-تتراهیدروکانیابینول; Î9-Tetrahydrocannabinol; Anandamide; Fatty acid amide hydrolase; 2-arachidonoylglycerol; Drug discrimination; Rimonabant;